Mammalian Target of Rapamycin Inhibitor Induced Complete Remission of a Recurrent Subependymal Giant Cell Astrocytoma in a Patient Without Features of Tuberous Sclerosis Complex

2016 ◽  
Vol 63 (7) ◽  
pp. 1276-1278 ◽  
Author(s):  
Deepika Appalla ◽  
Andres Depalma ◽  
Stanley Calderwood
2019 ◽  
Vol 10 ◽  
Author(s):  
Anna C. Jansen ◽  
Elena Belousova ◽  
Mirjana P. Benedik ◽  
Tom Carter ◽  
Vincent Cottin ◽  
...  

2014 ◽  
Vol 30 (9) ◽  
pp. 1192-1195 ◽  
Author(s):  
Shinobu Fukumura ◽  
Toshihide Watanabe ◽  
Rumiko Takayama ◽  
Kimio Minagawa ◽  
Hiroyuki Tsutsumi

2013 ◽  
Vol 29 (9) ◽  
pp. NP54-NP57 ◽  
Author(s):  
Giulia Prato ◽  
Maria Margherita Mancardi ◽  
Maria Giuseppina Baglietto ◽  
Sara Janis ◽  
Nadia Vercellino ◽  
...  

2015 ◽  
Vol 16 (2) ◽  
pp. 134-137 ◽  
Author(s):  
Thomas L. Beaumont ◽  
Jakub Godzik ◽  
Sonika Dahiya ◽  
Matthew D. Smyth

The authors report the case of a 14-year-old male with a subependymal giant cell astrocytoma (SEGA) that occurred in the absence of tuberous sclerosis complex (TSC). The patient presented with progressive headache and the sudden onset of nausea and vomiting. Neuroimaging revealed an enhancing left ventricular mass located in the region of the foramen of Monro with significant mass effect and midline shift. The lesion had radiographic characteristics of SEGA; however, the diagnosis remained unclear given the absence of clinical features of TSC. The patient underwent gross-total resection of the tumor with resolution of his symptoms. Although tumor histology was consistent with SEGA, genetic analysis of both germline and tumor DNA revealed no TSC1/2 mutations. Similarly, a comprehensive clinical evaluation failed to reveal any clinical features characteristic of TSC. Few cases of SEGA without clinical or genetic evidence of TSC have been reported. The histogenesis, genetics, and clinical approach to this rare lesion are briefly reviewed.


Sign in / Sign up

Export Citation Format

Share Document